Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page
- Check7 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the study record history, superseding the previous v3.6.3 entry.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record history now shows a new revision entry 'Revision: v3.6.3' and removes the previous 'Revision: v3.6.2'. This updates the version history displayed for the record.SummaryDifference0.1%

- Check35 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.2) and the previous revision (v3.6.0) is removed from the current listing.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a recruitment status note 'No longer looking for participants' and updated the record to revision 'v3.6.0', while removing the previous revision 'v3.5.5' from the history.SummaryDifference0.4%

- Check57 days agoChange DetectedA new revision entry v3.5.5 has been added to the page history. The previous revision v3.5.4 has been removed.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a new site release. The change affects only the version label and does not modify the study details or displayed information.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.